Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha‐1‐anti‐trypsin deficiency
Open accessThe DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Alpha‐1‐anti‐trypsin deficiency is the most common genetic cause of liver disease in children and liver transplantation is currently the only available treatment. Enhancement of liver autophagy increases degradation of mutant, hepatotoxic alpha‐1‐anti‐trypsin (ATZ). We investigated the therapeutic potential of liver‐directed gene transfer of transcription factor EB (TFEB), a master gene that regulates lysosomal function and autophagy, in PiZ transgenic mice, recapitulating the human hepatic disease. Hepatocyte TFEB gene transfer resulted in dramatic reduction of hepatic ATZ, liver apoptosis and fibrosis, which are key features of alpha‐1‐anti‐trypsin deficiency. Correction of the liver phenotype resulted from increased ATZ polymer degradation mediated by enhancement of autophagy flux and reduced ATZ monomer by decreased hepatic NFκB activation and IL‐6 that drives ATZ gene expression. In conclusion, TFEB gene transfer is a novel strategy for treatment of liver disease of alpha‐1‐anti‐trypsin deficiency. This study may pave the way towards applications of TFEB gene transfer for treatment of a wide spectrum of human disorders due to intracellular accumulation of toxic proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| AATD | Liver‐specific knock‐in of human Tfeb | Reduced liver apoptosis and fibrosis, lined to promoted clearance of hepatotoxic ATZ in PiZ mice after autophagy activation | Pastore et al (2013) |”
From Autophagy in major human diseases (2021) · cites this paper as Pastore et al, 2013
In the citing paper
“In this scenario, the increase in lysosomal biogenesis imposed on hepatocytes by Tfeb gene transfer in mice (Pastore et al, 2013), or the pharmacological activation of autophagy by carbamazepine or rapamycin, reduces the burden of fibrotic lesions in AATD mouse liver (Allaire et al, 2019).”
From Autophagy in major human diseases (2021) · cites this paper as Pastore et al, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 1×
“SQSTM1/p62 is incorporated into completed autophagosome and are degraded in autolysosomes, thus serving as a read-out of autophagic degradation (Klionsky et al, 2012; Pankiv et al, 2007).”
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 1×
“SQSTM1/p62 is incorporated into completed autophagosome and are degraded in autolysosomes, thus serving as a read-out of autophagic degradation (Klionsky et al, 2012; Pankiv et al, 2007).”
Self-citationTFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365 · cited 1×
“Transcription factor EB (TFEB) is a master gene that regulates the number and function of lysosomes and autophagy (Medina et al, 2011; Sardiello et al, 2009; Settembre et al, 2011).”
Self-citationA Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543 · cited 3×
“TFEB-3xFLAG HeLa stable cell lines (HeLa-CF7; Sardiello et al, 2009) and HeLa untransfected cells were cultured in DMEM with 10% foetal bovine serum (FBS) and 5% penicillin/streptomycin and transiently transfected with pcDNA3.”
Self-citationImpairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“TFEB-mediated increase of ATZ clearance was not observed in Atg7 (cid:2) / (cid:2) MEFs (Komatsu et al, 2005), thus showing that functioning autophagy is needed for TFEB-mediated increase of ATZ clearance (Fig 1B and D).”
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M. C., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.32 · Cited by 1,920
Self-citationAdenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864 · cited 1×
“…the results of the present study were obtained with the HDAd vector, similar outcomes are expected with TFEB gene transfer by other gene therapy vectors, such as recombinant adeno-associated viral (AAV) vectors that has recently generated encouraging results in humans (Nathwani et al, 2011).”
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677 · cited 2×
“However, shRNA delivered by gene therapy vectors has raised concerns because severe toxicity and lethality have been reported in mice (Grimm et al, 2006). shRNA-mediated saturation of the exportin-5 pathway, which shuttles cellular micro-RNA (miRNA) from nucleus to cyto-plasm, has been proposed as…”
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
A simplified method for the analysis of hydroxyproline in biological tissues
Kesava Reddy, G., & Enwemeka, C. S. (1996) · Clinical Biochemistry · doi:10.1016/0009-9120(96)00003-6 · Cited by 1,296
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.7.818 · Cited by 911
Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 Infants
Sveger, T. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606102942404 · Cited by 796
Translational control in the endoplasmic reticulum stress response
Ron, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216784 · Cited by 726
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Medina, D. L., Fraldi, A., Bouche, V., Annunziata, F., Mansueto, G., Spampanato, C., Puri, C., Pignata, A., Martina, J. A., Sardiello, M., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.016 · Cited by 716
Self-citationCoupling of a Signal Response Domain in IκBα to Multiple Pathways for NF-κB Activation
Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., & Ballard, D. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2809 · Cited by 684
Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with Emphysema
Wewers, M. D., Casolaro, M. A., Sellers, S. E., Swayze, S. C., McPhaul, K. M., Wittes, J. T., & Crystal, R. G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704233161704 · Cited by 641
Hidvegi, T., Ewing, M., Hale, P., Dippold, C., Beckett, C., Kemp, C., Maurice, N., Mukherjee, A., Goldbach, C., Watkins, S., et al. (2010) · Science · doi:10.1126/science.1190354 · Cited by 607
Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin Deficiency
Eriksson, S., Carlson, J., & Velez, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141202 · Cited by 580
Stoller, J., Snider, G., Brantly, M., Fallat, R., Stockley, R., Turino, G., Konietzko, N., Dirksen, A., Eden, E., Fallat, R., et al. (2005) · Pneumologie · doi:10.1055/s-2004-830176 · Cited by 477
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
Thomas, K. J., McCoy, M. K., Blackinton, J., Beilina, A., van der Brug, M., Sandebring, A., Miller, D., Maric, D., Cedazo-Minguez, A., & Cookson, M. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq430 · Cited by 454
Morral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409
I kappa B epsilon, a novel member of the Ikappa B family, controls RelA and cRel NF-kappa B activity
Whiteside, S. T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1413 · Cited by 395
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.
Carlson, J. A., Rogers, B. B., Sifers, R. N., Finegold, M. J., Clift, S. M., DeMayo, F. J., Bullock, D. W., & Woo, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113999 · Cited by 329
Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., Rouhani, F., Conlon, T. J., Calcedo, R., Betts, M. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904514106 · Cited by 327 · cited 1×
“…lung disease due to AAT deficiency can be prevented by protein augmentation therapy (American Thoracic/European Respiratory Society, 2003; Wewers et al, 1987) or replenishment of the deficient gene product via AAV-mediated muscle-directed gene therapy (Brantly et al, 2009; Flotte et al, 2004).”
Improved system for helper-dependent adenoviral vector production
Palmer, D., & Ng, P. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.014 · Cited by 290
Self-citationTeckman, J. H., & Perlmutter, D. H. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.5.g961 · Cited by 274
Self-citationArnaudeau, S., Kelley, W. L., Walsh, J. V., & Demaurex, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103274200 · Cited by 269
Kamimoto, T., Shoji, S., Hidvegi, T., Mizushima, N., Umebayashi, K., Perlmutter, D. H., & Yoshimori, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509409200 · Cited by 259 · cited 1×
“Autophagy has been previously shown to be involved in ATZ degradation (Hidvegi et al, 2010; Kamimoto et al, 2006; Teckman and Perlmutter, 2000; Teckman et al, 2002).”
Brunetti-Pierri, N., Palmer, D. J., Beaudet, A. L., Carey, K. D., Finegold, M., & Ng, P. (2004) · Human Gene Therapy · doi:10.1089/10430340460732445 · Cited by 256
Self-citationThe Natural History of Liver Disease in (α1‐Antitrypsin Deficient Children
SVEGER, T. (1988) · Acta Paediatrica · doi:10.1111/j.1651-2227.1988.tb10767.x · Cited by 245
Hidvegi, T., Schmidt, B. Z., Hale, P., & Perlmutter, D. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508652200 · Cited by 241
Kim, I.-H., Józkowicz, A., Piedra, P. A., Oka, K., & Chan, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241506298 · Cited by 222
Mironov, A. A., Beznoussenko, G. V., Nicoziani, P., Martella, O., Trucco, A., Kweon, H.-S., Di Giandomenico, D., Polishchuk, R. S., Fusella, A., Lupetti, P., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108073 · Cited by 214
Self-citationMitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency
Teckman, J. H., An, J.-K., Blomenkamp, K., Schmidt, B., & Perlmutter, D. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00175.2003 · Cited by 202
Self-citationKhandelwal, P. J., Herman, A. M., Hoe, H.-S., Rebeck, G. W., & Moussa, C. E. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr091 · Cited by 182
Rudnick, D. A., & Perlmutter, D. H. (2005) · Hepatology · doi:10.1002/hep.20815 · Cited by 178
Lawless, M. W., Greene, C. M., Mulgrew, A., Taggart, C. C., O’Neill, S. J., & McElvaney, N. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5722 · Cited by 172
Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.
Carlson, J. A., Rogers, B. B., Sifers, R. N., Hawkins, H. K., Finegold, M. J., & Woo, S. L. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113580 · Cited by 160
Increased risk of chronic liver failure in adults with heterozygous α-antitrypsin deficiency
Graziadei, I. W., Joseph, J. J., Wiesner, R. H., Therneau, T. M., Batts, K. P., & Porayko, M. K. (1998) · Hepatology · doi:10.1002/hep.510280421 · Cited by 150
Toietta, G., Mane, V. P., Norona, W. S., Finegold, M. J., Ng, P., McDonagh, A. F., Beaudet, A. L., & Lee, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500930102 · Cited by 140
Self-citationElectron Tomography of Large, Multicomponent Biological Structures
Perkins, G. A., Renken, C. W., Song, J.-J., Frey, T., Young, S. J., Lamont, S., Martone, M. E., Lindsey, S., & Ellisman, M. H. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3920 · Cited by 123
Kaushal, S., Annamali, M., Blomenkamp, K., Rudnick, D., Halloran, D., Brunt, E. M., & Teckman, J. H. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009297 · Cited by 122
Self-citationMueller, C., Tang, Q., Gruntman, A., Blomenkamp, K., Teckman, J., Song, L., Zamore, P. D., & Flotte, T. R. (2012) · Molecular Therapy · doi:10.1038/mt.2011.292 · Cited by 117
Self-citationChromosomal Integration of Adenoviral Vector DNA In Vivo
Stephen, S. L., Montini, E., Sivanandam, V. G., Al-Dhalimy, M., Kestler, H. A., Finegold, M. J., Grompe, M., & Kochanek, S. (2010) · Journal of Virology · doi:10.1128/jvi.00751-10 · Cited by 106
Liu, S., & Lu, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001237 · Cited by 104
Lindblad, D. S., Blomenkamp, K., & Teckman, J. H. (2007) · Hepatology · doi:10.1002/hep.21822 · Cited by 103
Self-citationFasting in α1-antitrypsin deficient liver: constitutive activation of autophagy
Teckman, J. H., An, J.-K., Loethen, S., & Perlmutter, D. H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2002 · Cited by 99
Self-citationBrunetti-Pierri, N., Stapleton, G. E., Law, M., Breinholt, J., Palmer, D. J., Zuo, Y., Grove, N. C., Finegold, M. J., Rice, K., Beaudet, A. L., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.257 · Cited by 92
Self-citationα1-Antitrypsin Deficiency in 26-Year-Old Subjects
Piitulainen, E., Carlson, J. A., Ohlsson, K., & Sveger, T. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2076 · Cited by 91
Flotte, T. R. (2004) · Human Gene Therapy · doi:10.1089/1043034041361190 · Cited by 91
Perlmutter, D. H. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.103 · Cited by 89
Helper-dependent adenoviral vectors for liver-directed gene therapy
Brunetti-Pierri, N., & Ng, P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr143 · Cited by 81
Self-citationBrunetti-Pierri, N., Nichols, T. C., McCorquodale, S., Merricks, E., Palmer, D. J., Beaudet, A. L., & Ng, P. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.811 · Cited by 79
Self-citationBrunetti-Pierri, N., Stapleton, G. E., Palmer, D. J., Zuo, Y., Mane, V. P., Finegold, M. J., Beaudet, A. L., Leland, M. M., Mullins, C. E., & Ng, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300102 · Cited by 78
Self-citationBrunetti-Pierri, N., Ng, T., Iannitti, D. A., Palmer, D. J., Beaudet, A. L., Finegold, M. J., Carey, K. D., Cioffi, W. G., & Ng, P. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.391 · Cited by 73
Self-citationBrunetti-Pierri, N., Palmer, D. J., Mane, V., Finegold, M., Beaudet, A. L., & Ng, P. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.001 · Cited by 67
Self-citationAn, J.-K., Blomenkamp, K., Lindblad, D. S., & Teckman, J. H. (2005) · Hepatology · doi:10.1002/hep.20508 · Cited by 62
Self-citationCruz, P. E., Mueller, C., Cossette, T. L., Golant, A., Tang, Q., Beattie, S. G., Brantly, M., Campbell‐Thompson, M., Blomenkamp, K., Teckman, J. H., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700629 · Cited by 61
Self-citationAlpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis
Mencin, A., Seki, E., Osawa, Y., Kodama, Y., De Minicis, S., Knowles, M., & Brenner, D. A. (2007) · Hepatology · doi:10.1002/hep.21832 · Cited by 59
Ross, P. J., Kennedy, M. A., & Parks, R. J. (2009) · Journal of Virology · doi:10.1128/jvi.00796-09 · Cited by 46
Morgan, K., Scobie, G. A., Marsters, P., & Kalsheker, N. A. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00064-1 · Cited by 46
High Prevalence of α‐1‐Antitrypsin Heterozygosity in Children With Chronic Liver Disease
Campbell, K. M., Arya, G., Ryckman, F. C., Alonso, M., Tiao, G. M., Balistreri, W. F., & Bezerra, J. A. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000243434.54958.21 · Cited by 44
Brunetti‐Pierri, N., Liou, A., Patel, P., Palmer, D. J., Grove, N. C., Finegold, M. J., Piccolo, P., Donnachie, E., Rice, K., Beaudet, A. L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.143 · Cited by 42
Self-citationGene therapy for human α1-antitrypsin deficiency in an animal model using SV40-Derived vectors
Duan, Y., Wu, J., Zhu, J., Liu, S.-L., Ozaki, I., Strayer, D. S., & Zern, M. Α. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.058 · Cited by 38
Alam, S., Wang, J., Janciauskiene, S. M., & Mahadeva, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.025 · Cited by 33
Progress Towards Liver and Lung-Directed Gene Therapy with Helper- Dependent Adenoviral Vectors
Brunetti‐Pierri, N., & Ng, P. (2009) · Current Gene Therapy · doi:10.2174/156652309789753310 · Cited by 32
Self-citationRare deficiency types of alpha 1-antitrypsin: electrophoretic variation and DNA haplotypes.
Cox, D. W., & Billingsley, G. D. (1989) · Europe PMC (PubMed Central) · Cited by 31
Brunetti‐Pierri, N., Grove, N. C., Zuo, Y., Edwards, R., Palmer, D. J., Cerullo, V., Teruya, J., & Ng, P. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.084 · Cited by 24
Self-citationGene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
Greene, C. M., McLean, & McElvaney, N. G. (2009) · Biologics · doi:10.2147/btt.s4718 · Cited by 21
Cited by
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Self-citationAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationLysosomes as dynamic regulators of cell and organismal homeostasis
Ballabio, A., & Bonifacino, J. S. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0185-4 · Cited by 1,469
Self-citationNapolitano, G., & Ballabio, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.146365 · Cited by 845
Self-citationMitophagy in human health, ageing and disease
Picca, A., Faitg, J., Auwerx, J., Ferrucci, L., & D’Amico, D. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00930-8 · Cited by 635
Metadata
- Authors
- Pastore, N., Blomenkamp, K., Annunziata, F., Piccolo, P., Mithbaokar, P., Maria Sepe, R., Vetrini, F., Palmer, D., Ng, P., Polishchuk, E., Iacobacci, S., Polishchuk, R., Teckman, J., Ballabio, A., & Brunetti‐Pierri, N.
- Affiliations
- Telethon Institute Of Genetics And Medicine (IT)
- Cardinal Glennon Children’s Medical Center (US)
- Baylor College of Medicine (US)
- Federico II University Hospital (IT)
- Corresponding author
- Brunetti‐Pierri, Nicola
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2013-02-04
- Volume
- 5
- Issue
- 3
- Pages
- 397-412
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3598080
- OpenAlex
- W1842277521
- Cited by
- 142
- References
- 71
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 13 · 2020: 11 · 2019: 15 · 2018: 8 · 2017: 15 · 2016: 19 · 2015: 11 · 2014: 17 · 2013: 10
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Alpha-1 Foundation
- Ministero della Salute
- FP7 Ideas: European Research Council (250154)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- TFEB, autophagy, gene transfer, protein clearance, liver fibrosis, liver apoptosis, NF-κB, interleukin-6, lysosomal function
- MeSH terms
- Autophagy-Related Protein 7, alpha 1-Antitrypsin, Animals, Autophagy, Disease Models, Animal, HeLa Cells, Humans, Liver, Liver Cirrhosis, Lysosomes, Mice, Inbred C57BL, Mice, Transgenic, Microtubule-Associated Proteins, Papio, Phenotype, Time Factors, Transfection, Genetic Therapy, Interleukin-6, NF-kappa B, Apoptosis, Gene Transfer Techniques, Mice, Knockout, alpha 1-Antitrypsin Deficiency, Genetic Predisposition to Disease, Mutation, Missense, Mice, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.